Regeneron Pharmaceuticals (REGN)

Executive Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. More Details


Trading at 11.7% below our estimate of its fair value

Earnings are forecast to grow 9.64% per year

Earnings grew by 47.2% over the past year

Risk Analysis

Significant insider selling over the past 3 months

Snowflake Analysis

Outstanding track record with excellent balance sheet.

Similar Companies

Search for a company to compare.